Session 6_Pharmacokinetics Of Drug Interactions Flashcards

1
Q

What is a drug interaction?

A

A modification of the expected drug response in the patient as a result of exposure to another drug or substance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What types of drug interactions are there?

A
  • Drug-drug interactions
  • Food-drug interactions
  • Chemical-drug interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What can cause an alteration in pharmacokinetics due to drug interactions?

A
  • Absorption
  • Distribution
  • Elimination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are drug-drug interactions (DDI)?

A

A serious concern in pharmacotherapy where the pharmacological effect of a victim drug is exaggerated or suppressed by a perpetrator drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How can pharmacokinetic interactions be classified?

A
  • Absorption interactions
  • Distribution interactions
  • Metabolism interactions
  • Excretion interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are absorption interactions?

A

Interactions where the absorption of a drug is altered, commonly occurring in the gastrointestinal tract.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List the factors that can alter gastrointestinal absorption.

A
  • Altered pH
  • Altered intestinal flora
  • Complexation or chelation
  • Drug-induced mucosal damage
  • Altered motility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What effect does altered gastric pH have on drug absorption?

A

Non-ionized forms of drugs are more lipid soluble and more readily absorbed than ionized forms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do antibiotics affect intestinal flora and drug absorption?

A

Antibiotics can kill normal intestinal flora, influencing the absorption of other drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is complexation or chelation in drug interactions?

A

It occurs when one drug interacts with another to form insoluble complexes, reducing absorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the impact of altered GI motility on drug absorption?

A
  • Increased motility decreases bioavailability
  • Decreased motility Decreases gastric emptying time, reducing bioavailability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are distribution interactions?

A

Interactions that occur due to displaced protein binding, affecting the free levels of drugs in the plasma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is enzyme inhibition in metabolism interactions?

A

A decrease in the rate of metabolism of a drug by another, leading to increased concentration of the target drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is enzyme induction?

A

A drug may induce the enzyme responsible for the metabolism of another drug, potentially increasing its clearance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the role of CYP450 enzymes in drug metabolism?

A

CYP450 enzymes are the major metabolizing enzymes involved in phase I metabolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which CYP450 enzyme metabolizes the largest percentage of drugs?

A

CYP3A4, metabolizing approximately 60% of drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What happens during renal excretion interactions?

A

Drugs can be actively secreted or reabsorbed in the proximal tubules, affecting their elimination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is pharmacokinetic boosting?

A

A strategy to optimize therapeutic properties of a drug by inhibiting enzymes or enhancing absorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the management options for drug interactions?

A
  • Avoiding the combination
  • Adjusting the dose
  • Spacing dosing times
  • Monitoring for early detection
  • Providing information on patient risk factors
  • Using computerized drug interaction screening systems
20
Q

What factors affect the likelihood of drug interactions?

A
  • Genes
  • Physiology
  • Age
  • Lifestyle
  • Underlying diseases
  • Drug doses
  • Duration of therapy
  • Timing of administration
21
Q

What is the ‘dose-related reference range’ in therapeutic drug monitoring?

A

The mean ± SD range of the trough concentration of a drug under steady-state conditions.

22
Q

What does the concentration to dose ratio (C/D) indicate?

A

It is used to analyze pharmacokinetic abnormalities and estimate the dose required to achieve a target concentration.

23
Q

What is the metabolite to parent compound ratio (MPR)?

A

It measures the activity of metabolizing enzymes in vivo and helps identify abnormal metabolism.

24
Q

What is an example of a serious drug interaction with warfarin?

A

Warfarin plus ciprofloxacin, clarithromycin, erythromycin, or metronidazole increases the effect of warfarin.

25
Q

True or False: Pharmacokinetic interactions can only occur with drug-drug interactions.

A

False, they can also occur with food-drug and chemical-drug interactions.

26
Q

Fill in the blank: The liver is the major site of _______.

A

[drug metabolism]

27
Q

What is the Clinical Global Impressions (CGI-I) scale used for?

A

Assessment of patient improvement or response to treatment.

28
Q

What are the low and high DRC factors for venlafaxine?

A

Low = 0.12; High = 0.36.

29
Q

What are the low and high DRC factors for O-desmethyl venlafaxine?

A

Low = 0.78; High = 1.3.

30
Q

What are the low and high DRC factors for N-desmethyl venlafaxine?

A

Low = 0.15; High = 0.33.

31
Q

Is venlafaxine a substrate of CYP2D6 and CYP2C19?

32
Q

What is the expected metabolite to parent compound ratio (MRP) of O-desmethyl venlafaxine to venlafaxine?

A

2.7 to 7.7.

33
Q

What is the expected metabolite to parent compound ratio (MRP) of N-desmethyl venlafaxine to venlafaxine?

A

0.28 to 0.85.

34
Q

What is levomepromazine known for?

A

GIT disturbance.

35
Q

What enzyme does smoking induce?

36
Q

What was the active moiety concentration of venlafaxine plus O-desmethyl venlafaxine in Clinical Case 1?

A

419 ng/mL.

37
Q

What is the therapeutic reference range for the active moiety concentration?

A

100 to 400 ng/mL.

38
Q

What is the expected dose-related reference range for venlafaxine at a dose of 225 mg/day?

A

27 - 81 ng/mL.

39
Q

What is the expected dose-related reference range for O-desmethylvenlafaxine at a dose of 225 mg/day?

A

176 - 293 ng/mL.

40
Q

What is the MPR of O-desmethylvenlafaxine to venlafaxine in Clinical Case 1?

41
Q

What does an MPR below the expected range indicate regarding CYP2D6?

A

Inhibition of the phenotype of CYP2D6.

42
Q

What is the MPR of N-desmethylvenlafaxine to venlafaxine?

43
Q

What can be inferred from a higher than expected concentration of N-desmethylvenlafaxine?

A

PM phenotype of CYP2D6.

44
Q

Can adverse drug reactions (ADRs) be linked to high concentrations of venlafaxine?

A

Yes, likely due to drug-drug interaction and old age.

45
Q

What recommendation was made to manage the case?

A

Dose reduction of venlafaxine or replacement of levomepromazine.

46
Q

Fill in the blank: The expected active moiety concentration should amount to ______.

A

203-374 ng/mL.

47
Q

True or False: Levomepromazine is a CYP inhibitor.